| Patents for C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes (2,829) |
|---|
| 06/10/2004 | WO2004048591A2 Methods for cohort selection and longevity studies |
| 06/10/2004 | WO2004047767A2 Methods for identifying risk of breast cancer and treatments thereof |
| 06/10/2004 | WO2004047623A2 Methods for identifying risk of breast cancer and treatments thereof |
| 06/10/2004 | WO2004047514A2 Methods for identifying risk of breast cancer and treatments thereof |
| 06/10/2004 | WO2004029278A3 Aav itr-mediated modulation |
| 06/10/2004 | WO2004011669A3 Apparatus and methods for binding molecules and cells |
| 06/10/2004 | US20040110161 Identifying genetic aberrations in nucleic acid sequences using base mispairing-binding proteins; genomics |
| 06/10/2004 | CA2507469A1 Porcine polymorphisms and methods for detecting them |
| 06/10/2004 | CA2505784A1 Methods for identifying risk of breast cancer and treatments thereof |
| 06/10/2004 | CA2504498A1 Molecular nephrotoxicology modeling |
| 06/10/2004 | CA2485950A1 Methods for cohort selection and longevity studies |
| 06/09/2004 | CN1502697A Alzhimer's disease secretase |
| 06/09/2004 | CN1502696A Alzheimer's disease secretase |
| 06/09/2004 | CN1502692A Alzheimer's disease secretase |
| 06/03/2004 | WO2004046370A2 Digital karyotyping |
| 06/03/2004 | WO2004046369A2 Nucleic acid sequence detection |
| 06/03/2004 | US20040106141 Methods and materials for examining pathways associated with glioblastoma progression |
| 06/03/2004 | CA2505636A1 Nucleic acid sequence detection |
| 05/27/2004 | WO2004044228A2 A continuous-read assay for the detection of de novo hcv rna polymerase activity |
| 05/27/2004 | WO2004044227A2 Ethylenedicysteine (ec)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 05/27/2004 | WO2004044226A2 Induction of cellular senescence by cdk4 disruption for tumor supression and regression |
| 05/27/2004 | WO2004044225A2 Methods for identifying dna copy number changes |
| 05/27/2004 | WO2004044224A2 Branched polymeric prodrugs of vancomycin |
| 05/27/2004 | WO2004044223A2 Prodrugs of vancomycin with hydrolysis resistant polymer linkers |
| 05/27/2004 | WO2004044222A2 Polymeric prodrugs of vancomycin |
| 05/27/2004 | WO2004044220A2 Flaviviris fusion inhibitors |
| 05/27/2004 | WO2004044218A2 Methods and materials for examining pathways associated with glioblastoma progression |
| 05/27/2004 | WO2004044217A2 Dna sequences from tcd genomic region of photorhabdus luminescens |
| 05/27/2004 | US20040103455 Comprises nucleotide sequences coding insecticidal protein for generation and propagation of insect resistant plants; biological pest control |
| 05/27/2004 | CA2505807A1 Dna sequences from tcd genomic region of photorhabdus luminescens |
| 05/27/2004 | CA2505537A1 Ethylenedicysteine (ec)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 05/27/2004 | CA2505472A1 Methods for identifying dna copy number changes |
| 05/27/2004 | CA2504042A1 Methods and materials for examining pathways associated with glioblastoma progression |
| 05/27/2004 | CA2503303A1 Flavivirus fusion inhibitors |
| 05/21/2004 | WO2004042346A2 Methods and compositions for diagnosing and monitoring transplant rejection |
| 05/21/2004 | WO2004042074A2 Methods for the identification of agents that modulate the structure and processing of a membrane bound precursor protein |
| 05/21/2004 | WO2004042073A2 Method for detecting nucleic acids |
| 05/21/2004 | WO2004042072A2 Quantitative analysis of protein isoforms using matrix-assisted laser desorption/ionization time of flight mass spectrometry |
| 05/21/2004 | WO2003042395A3 Programmable and autonomous computing machine made of biomolecules |
| 05/21/2004 | CA2504922A1 Methods for the identification of agents that modulate the structure and processing of a membrane bound precursor protein |
| 05/21/2004 | CA2502413A1 Quantitative analysis of protein isoforms using matrix-assisted laser desorption/ionization time of flight mass spectrometry |
| 05/21/2004 | CA2483481A1 Method for diagnosing and monitoring cardiac transplant rejection |
| 05/20/2004 | US20040096892 Identifying chromosomal aberration associated with cell proliferative and hereditary disorders; cancer diagnosis |
| 05/19/2004 | EP1419383A2 System and method for storing mass spectrometry data |
| 05/13/2004 | WO2004039999A2 Essential dna enclosed proteins of drosphophilia melanogaster |
| 05/11/2004 | US6734284 Exhibits high affinity for the gfr alpha 3- ret receptor complex and unique subregions in its amino acid sequence |
| 05/11/2004 | US6733883 Fluorinated dendrons and self-organizing ultrahigh density nanocylinder compositions |
| 05/11/2004 | CA2222581C Oligonucleotide tags for sorting and identification |
| 05/06/2004 | WO2004038037A2 Controlled alignment of nano-barcodes encoding specific information for scanning probe microscopy (spm) reading |
| 05/06/2004 | US20040086867 Method for detecting nucleic acid |
| 04/29/2004 | WO2004035806A2 Methods and nucleic acids for the analysis of cpg dinucleotide methylation status associated with the calcitonin gene |
| 04/29/2004 | WO2004005534A3 Screening for alzheimer's disease |
| 04/29/2004 | WO2003060147A3 Method of obtaining purified enterochromaffin cells and methods of using same |
| 04/29/2004 | US20040081994 Measuring efficiency of exercise; measuring isotropic patterns; sensitivity to cardiovascular disorders |
| 04/22/2004 | WO2003070965A8 The eaat2 promoter and uses thereof |
| 04/22/2004 | WO2003040400A8 Methods for detecting and quantifying binding and inhibition of binding of species to nucleic acids |
| 04/22/2004 | US20040076998 Sequencing method using magnifying tags |
| 04/22/2004 | US20040076627 Humanised antibodies |
| 04/22/2004 | US20040076607 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 04/21/2004 | EP1409737A2 Methods for detecting and treating the early onset of aging-related conditions |
| 04/21/2004 | EP1409723A2 Method of determining dihydropyrimidine dehydrogenase gene expression |
| 04/21/2004 | EP1409710A1 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 04/21/2004 | CN1146668C Oligonucleotide tags for sorting and identification |
| 04/20/2004 | US6723513 Sequencing method using magnifying tags |
| 04/15/2004 | WO2004031407A1 DETECTING THE RISK OF CARDIOVASCULAR DISEASES BY DETECTING MUTATIONS IN GENES, INCLUDING GENES ENCODING a2b-ADRENOCEPTOR AND APOLIPOPROTEIN B |
| 04/15/2004 | WO2004031402A2 Methylation profile of cancer |
| 04/15/2004 | WO2003054212A8 A method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral dna |
| 04/15/2004 | WO2003044215A3 Methods for evaluating drug-resistance gene expression in the cancer patient |
| 04/15/2004 | WO2003043580A3 Methods for identifying and validating potential drug targets |
| 04/15/2004 | US20040072188 Comprises nucleotide sequences coding B-cell activating factor receptor (BAFF-R) for diagnosis, prevention, treatment and/or delay of cancers, lymphomas and autoimmune diseases |
| 04/15/2004 | US20040071693 Humanised antibodies |
| 04/15/2004 | CA2501481A1 Detecting the risk of cardiovascular diseases by detecting mutations in genes, including genes encoding a2b-adrenoceptor and apolipoprotein b |
| 04/13/2004 | US6720161 Immobilized substrate, separation gels and method for detecting enzymatic activity |
| 04/08/2004 | WO2004029280A2 Anti-hla assay and methods |
| 04/08/2004 | WO2004029278A2 Aav itr-mediated modulation |
| 04/08/2004 | WO2004028473A2 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 04/08/2004 | WO2004015129A3 Cell and tissue culture device |
| 04/08/2004 | WO2003070974A3 Mismatch repair detection |
| 04/08/2004 | US20040068762 Transgenic non-human mammals expressing a reporter nucleic acid under the regulation of androgen response elements |
| 04/08/2004 | CA2500397A1 Aav itr-mediated modulation |
| 04/08/2004 | CA2498483A1 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 04/07/2004 | EP1404695A2 Universal supports for oligonucleotide synthesis |
| 04/01/2004 | WO2004027082A2 Methods and compositions for detecting targets |
| 04/01/2004 | WO2004027081A2 Methods and composition for detecting targets |
| 04/01/2004 | WO2004027080A2 Method of extracting nucleic acids from microbial samples |
| 04/01/2004 | WO2004027078A2 Fluorinated dendrons and self-organizing ultrahigh density nanocylinder compositions |
| 04/01/2004 | WO2004016804A3 Assay for detection of antigen in bodily fluid |
| 04/01/2004 | WO2003102219A9 Improved pseudotyped retroviruses |
| 04/01/2004 | WO2003100082A8 Methods of determining precise herg interactions and altering compounds based on said interactions |
| 04/01/2004 | WO2002072870A3 Dry solid medium for storage and analysis of genetic material |
| 04/01/2004 | US20040063124 Methods and apparatus for preparing and assaying biological samples to determine protein concentration |
| 04/01/2004 | US20040062927 Fluorinated dendrons and self-organizing ultrahigh density nanocylinder compositions |
| 04/01/2004 | US20040062761 Nucleic acid and corresponding protein entitled 151P3D4 useful in treatment and detection of cancer |
| 04/01/2004 | CA2499360A1 Methods and compositions for detecting targets |
| 04/01/2004 | CA2499077A1 Methods and composition for detecting targets |
| 03/31/2004 | EP1402260A2 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 03/30/2004 | US6713270 Dna encoding a novel steroid receptor is introduced into cell with reporter gene, potential ligand is incubated with cell, production of reporter protein means ligand binds receptor |
| 03/25/2004 | WO2004024941A2 Biochemical methods for measuring metabolic fitness of tissues or whole organisms |
| 03/25/2004 | WO2004024939A2 Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof |
| 03/25/2004 | WO2004024937A2 Virulence-associated nucleic acids and proteins and uses thereof |